<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02363582</url>
  </required_header>
  <id_info>
    <org_study_id>SCMCIRB-K2013005</org_study_id>
    <nct_id>NCT02363582</nct_id>
  </id_info>
  <brief_title>The Impact of a Prebiotics and Lactoferrin Containing Infant Formula on Stool Characteristics in Healthy Term Infants</brief_title>
  <official_title>The Impact of a Prebiotics and Lactoferrin Containing Infant Formula on Stool Characteristics in Healthy Term Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human milk (HM) is considered the gold standard nutrient for infants, which contains a lot of&#xD;
      beneficial nutrients such as prebiotics and lactoferrin. Previous studies have shown that&#xD;
      both prebiotics and lactoferrin play important roles in generating a bifidobacteria-dominated&#xD;
      colonic microflora.The purpose of this study is to investigate the stool&#xD;
      characteristics,acceptability, and gastrointestinal tolerance in term infants fed a starting&#xD;
      infant formula supplemented with prebiotics and lactoferrin.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Human milk (HM) is considered the gold standard nutrient for infants, which contains a lot of&#xD;
      beneficial nutrients such as prebiotics and lactoferrin. Previous studies have shown that&#xD;
      both prebiotics and lactoferrin play important roles in generating a bifidobacteria-dominated&#xD;
      colonic microflora as well as the intestinal immune systems. The purpose of this study is to&#xD;
      investigate the stool characteristics（including intestinal microbiota） acceptability, and&#xD;
      gastrointestinal tolerance in infants fed a starting infant formula supplemented with&#xD;
      prebiotics and lactoferrin, and compared these data with infants on exclusively breast&#xD;
      feeding.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>growth</measure>
    <time_frame>6 weeks</time_frame>
    <description>Head circumferences and weight gain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal tolerance and safety</measure>
    <time_frame>6 weeks</time_frame>
    <description>daily records of vomiting and stool characteristics; records of infection episodes and other adverse effects</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intestinal microbiota</measure>
    <time_frame>6 weeks</time_frame>
    <description>test the bacteria composition in baby stools by DNA sequencing technology</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Infant Formula Intolerance</condition>
  <arm_group>
    <arm_group_label>Breast fed</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>healthy term infants on exclusively breast feeding , enrollment age: 30-50days old</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Formula fed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>healthy term infants on exclusively formula fed , enrollment age: 30-50days old</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>formula</intervention_name>
    <description>An infant formula contains prebiotics and lactoferrin</description>
    <arm_group_label>Formula fed</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  full-term with a birth weight ≥2,500 g&#xD;
&#xD;
          -  be in good health&#xD;
&#xD;
          -  without symptoms of diarrhea, and had not received antibiotics for at least 1 week&#xD;
             before enrollment&#xD;
&#xD;
          -  exclusively fed by breast milk or infant formula&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  preterm infant&#xD;
&#xD;
          -  with known diseases or currently taking medication drugs&#xD;
&#xD;
          -  mixed feeding&#xD;
&#xD;
          -  with symptoms of diarrhea&#xD;
&#xD;
          -  received antibiotics within 1 week&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Weeks</minimum_age>
    <maximum_age>7 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jiang Wu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xin Hua Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xin Hua Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200092</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <study_first_submitted>January 31, 2015</study_first_submitted>
  <study_first_submitted_qc>February 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2015</study_first_posted>
  <last_update_submitted>April 20, 2016</last_update_submitted>
  <last_update_submitted_qc>April 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Jiang WU</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

